Vitaros (Alprostadil) is an alternative, fast-acting prescription medication for the treatment of erectile dysfunction. Designed for topical use, in the form of disposable individual applicators, Studies show that Vitaros, once applied, can take effect within 5 minutes and may last from 1-2 hours.
HOW IT WORKS?
Vitaros contains a unique skin-permeation enhancer that facilitates the absorption of Alprostadil through the glans of the penis. Once absorbed, Alprostadil causes vasodilation of the blood vessels and an increase in the blood flow into the penis. This subsequently leads to an erection.
VITAROS® World’s Approvals
VITAROS® was also approved in August in Austria, Cyprus, the Czech Republic, Denmark, Finland, Greece, Iceland, Norway, Poland, Portugal, Romania and the Slovak Republic.
Canada Approval
HEALTH CANADA
November – 2010
European Decentralized
European Medicine Agency
June – 2013
United Kingdom
MHRA
August – 2013
Spain
Ministerio De Sanidad, Servicios Sociales E Igualdad
April – 2014
Netherlands
Ministry of Health, Welfare and Sport
August – 2013
Italy
November – 2013
Germany
BfArM
October – 2013
France
December – 2013
Luxembourg
April – 2014
Sweden
Government Offices of Sweden
August – 2013
Ireland
Department of Health
August – 2013
Belgium
January – 2014
Elis pharmaceuticals Ltd is the license holder of in the Middle East.